The stock may react negatively to the significant revenue and EPS miss, despite the guidance raise. The market will focus on the sustainability of the Food Safety growth and the execution of the Petrifilm transition. The announced divestiture is a positive for deleveraging but removes a growth segment.
Price Chart
Executive Summary
Neogen reported Q3 FY2026 revenue of $211.2M, missing consensus by 3.2% and declining 4.4% YoY, driven by a 20.1% drop in Animal Safety. Adjusted EPS was $0.09, missing estimates by $0.04. Despite the miss, the company raised full-year revenue guidance to $857-860M while maintaining Adjusted EBITDA guidance, citing progress in Food Safety (4.0% core growth) and Petrifilm transition. A $160M divestiture of the Genomics business was announced.
Key Financial Metrics
Key Facts
- Q3 revenue was $211.2M, down 4.4% YoY and below $218.0M consensus
- Adjusted EPS was $0.09, missing $0.13 consensus
- Food Safety segment grew 4.0% core, but Animal Safety declined 8.7% core due to supplier issues
- Company raised FY26 revenue guidance to $857-860M but maintained EBITDA guidance
- Announced $160M divestiture of Genomics business to Zoetis
Financial Impact
Revenue miss of $6.8M vs consensus, EPS miss of $0.04 vs consensus
Risk Factors
- Animal Safety segment continues to face significant supplier challenges
- Core revenue growth remains flat at 0.1% YoY
- Future performance depends on successful execution of Petrifilm transition
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-148851 |
| Document: neog-20260409.htm | 0001193125-26-148851 |
| Document: 0001193125-26-148851-index-headers.html | 0001193125-26-148851 |
| Document: 0001193125-26-148851-index.html | 0001193125-26-148851 |
| Document: 0001193125-26-148851.txt | 0001193125-26-148851 |
| 8-K Data (Synthetic) | 0001193125-26-148851 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 21, 2026 6w ago | DEFA14A | $11.95 $13.61 | ▲ +13.89% | ▲ +14.42% | $12.15 (+1.67%) |
Aug 7, 2026 8w ago | 8-K | $11.40 $11.89 | ▲ +4.25% | ▲ +5.17% | $12.15 (+6.58%) |
Jul 30, 2026 9w ago | 8-K | $11.53 $11.74 | ▲ +1.82% | ▼ −2.14% | $12.15 (+5.38%) |
Apr 20, 2026 23w ago | 8-K | $9.63 $8.56 | ▼ −11.11% | ▼ −15.31% | $12.15 (+26.17%) |
Apr 9, 2026 25w ago | 8-K | $10.04 $9.18 | ▼ −8.57% | ▼ −16.13% | $12.15 (+21.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access